P09382
Uniprot

PubMed
Kishor C, Ross R, Blanchard H.
Lactulose as a novel template for anticancer drug development targeting galectins. Chemical biology & drug design 2018

PubMed
Peterson, A., Collins, P.M., Huang, X., Kahl-Knutsson, B., Essenn, S., Zetterberg, F.R., Oredson, S., Leffler, H., Blanchard, H., Nilsson, U.J.
Aromatic heterocycle galectin-1 interactions for selective single-digit nM affinity ligands RSC Advances 2018

PubMed
Bertleff-Zieschang N, Bechold J, Grimm C, Reutlinger M, Schneider P, Schneider G, Seibel J.
Exploring the Structural Space of the Galectin-1-Ligand Interaction. Chembiochem : a European journal of chemical biology 2017

PubMed
Hsieh T, Lin H, Tu Z, Lin T, Wu S, Tseng Y, Liu F, Hsu S, Lin C.
Dual thio-digalactoside-binding modes of human galectins as the structural basis for the design of potent and selective inhibitors. Scientific reports 2016

PubMed
Hsieh, T.J., Lin, H.Y., Tu, Z., Huang, B.S., Wu, S.C., Lin, C.H.
Structural Basis Underlying the Binding Preference of Human Galectins-1, -3 and -7 for Galβ1-3/4GlcNAc. PLoS One 2015

PubMed
Collins PM, Oberg CT, Leffler H, Nilsson UJ, Blanchard H.
Taloside Inhibitors of Galectin-1 and Galectin-3. Chem. Biol. Drug Des. 2012

PubMed
Nesmelova IV, Ermakova E, Daragan VA, Pang M, Menendez M, Lagartera L, Solis D, Baum LG, Mayo KH
Lactose binding to galectin-1 modulates structural dynamics, increases conformational entropy, and occurs with apparent negative cooperativity. J. Mol. Biol. 2010

PubMed
Stannard KA, Collins PM, Ito K, Sullivan EM, Scott SA, Gabutero E, Darren Grice I, Low P, Nilsson UJ, Leffler H, Blanchard H, Ralph SJ.
Galectin inhibitory disaccharides promote tumour immunity in a breast cancer model. Cancer Lett. 2010

PubMed
Nishi N, Abe A, Iwaki J, Yoshida H, Itoh A, Shoji H, Kamitori S, Hirabayashi J, Nakamura T
Functional and structural bases of a cysteine-less mutant as a long-lasting substitute for galectin-1 Glycobiology 2008

PubMed
Lopez-Lucendo MF, Solis D, Andre S, Hirabayashi J, Kasai K, Kaltner H, Gabius HJ, Romero A
Growth-regulatory human galectin-1: crystallographic characterisation of the structural changes induced by single-site mutations and their impact on the thermodynamics of ligand binding J. Mol. Biol. 2004

PubMed
Lin, H.Y., Hsieh, T.J., Tu, Z., Huang, B.S., Wu, S.C., Chien, C.T., Hsu, S.T., Lin, C.H.
To be published. Structural basis of human galectin-1 inhibition with Ki values in the micro- to nanomolar range

PubMed
Lin, H.Y., Hsieh, T.J., Tu, Z., Huang, B.S., Wu, S.C., Chien, C.T., Hsu, S.T., Lin, C.H.
To be published. Structural basis of human galectin-1 inhibition with Ki values in the micro- to nanomolar range.

PubMed
Lin, H.Y., Hsieh, T.J., Tu, Z., Huang, B.S., Wu, S.C., Chien, C.T., Hsu, S.T., Lin, C.H.
Structural basis of human galectin-1 inhibition with Ki values in the micro- to nanomolar range. To be published.

PubMed
Lin, H.Y., Hsieh, T.J., Tu, Z., Huang, B.S., Wu, S.C., Chien, C.T., Hsu, S.T., Lin, C.H.
Structural basis of human galectin-1 inhibition with Ki values in the micro- to nanomolar range To be published.

PubMed
Saburi, H., Tanaka, T., Kunishima, N.
Crystal structure of Galectin-1 in the lactose-unbound state To be published.
Copyright Ⓒ UniLectin 2017-2020
CERMAV | CNRS | PIG | SIB | Terms of use
How to cite: F Bonnardel, J Mariethoz, S Salentin, X Robin, M Schroeder, S Perez, F Lisacek, A Imberty; UniLectin3D, a database of carbohydrate binding proteins with curated information on 3D structures and interacting ligands, Nucleic Acids Research, Nucleic Acids Research, Volume 47, Issue D1, 8 January 2019, Pages D1236–D1244, doi:10.1093/nar/gky832